Frank Karbe - Insider Trading & Ownership

Location: C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Summary: The estimated net worth of Frank Karbe is at least $6.9M dollars as of June 5, 2025. Frank Karbe is the Principal Fin'l & Accounting of Myovant Sciences Ltd. and owns shares of Myovant Sciences Ltd. stock worth about $5.73M. Frank Karbe is the Chief Financial Officer of Cidara Therapeutics, Inc. and owns shares of Cidara Therapeutics, Inc. (CDTX) stock worth about $857K. Frank Karbe is the Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $223K. Frank Karbe is the Chief Executive Officer, Director of Better Therapeutics, Inc. and owns shares of Better Therapeutics, Inc. stock worth about $89.5K.
Signature: /s/ Steven Basta, Attorney-in-Fact for Frank Karbe
All Insider Reports: All Insider Reports

Notify me when Frank Karbe files a new Insider Trading report.

Ownership of Frank Karbe

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
MYOV	Myovant Sciences Ltd.	Principal Fin'l & Accounting	$5.73M			Jul 7, 2021
CDTX	Cidara Therapeutics, Inc.	Chief Financial Officer	$857K			Feb 24, 2025
PHAT	Phathom Pharmaceuticals, Inc.	Director	$223K	+$99.1K	+79.7%	Jun 3, 2025
BTTX	Better Therapeutics, Inc.	Chief Executive Officer, Director	$89.5K			Dec 18, 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.